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Abstract  
Smoking is an important determinant of osteoporosis. There are a wide variety of mechanisms by which 
smoking induces bone toxic effects. Such mechanisms include alterations in calciotropic hormone metabolism 
and intestinal calcium absorbation, dysregulation in sex hormone production and metabolism, alterations in 
adrenal cortical hormone metabolism and direct cellular effects of cigarette use on bone cells. To assess the 
effect of smoking on vitamin D, serum parathyroid hormone (PTH) and calcium we studied 86 postmenopausal 
women (50-70 years), who were smokers previously or who were current smokers. Our results are compare with 
those of 34 women of the same age who had never smoked. Differences between the three groups were analyzed 
using one-way analysis of variance and Student’s unpaired t-test. Postmenopausal women who were current 
smokers had significantly reduced levels of serum 25OHD (P<0.01) and PTH (P<0.001). There was no 
difference in serum calcium between never smokers, ex-smoker and current smokers (P=0.184). The unchanged 
plasma calcium among smokers in spite of lower levels of PTH and 25OHD could be a result of a decreased 
calcium uptake in bone. 
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1.  Introduction 
Osteoporosis is a complex heterogeneous 
disorder characterized by an imbalance in bone 
remodeling which culminates in reduced BMD, 
deterioration of microarchitectural integrity of the 
bone, and increased risk of fracture. It has a major 
economic [1] and health impact. Osteoporotic 
fractures are associated with increased morbidity [2] 
and mortality [3]. 
Tobacco smoking is in most studies found to be 
associated with a low bone mass and an increased risk 
of osteoporotic fracture [4]. An increased bone loss 
has been registered in smokers [5].  
A direct toxic effect of tobacco smoking on bone 
cells is also a possibility. Other hormonal systems, 
glucocorticoids, pituitary, and thyroid hormones, may 
be affected by smoking. 
Parathyroid hormone (PTH) and vitamin D 
metabolites are crucial in the regulation of calcium 
homeostasis and bone metabolism. An effect of 
smoking on PTH or 25-hydroxyvitamin D (25OHD) 
levels has only been investigated in few studies [6,7,8] 
PTH regulates serum ionized calcium through 
alteration of bone resorption and renal calcium 
reabsorption [9] while 1,25 dihydroxyvitamin D 
(1,25-OH2-D) regulates intestinal calcium absorption 
[10, 11]. Two cross-sectional and cohort studies have 
demonstrated lower serum 25- hydroxyvitamin D (25-
OH-D) and 1,25-OH2-D levels in current smokers 
compared to nonsmokers [12,13]. The mechanisms 
whereby smoking could decrease circulating levels of 
PTH and vitamin D metabolites remain to be worked 
out. One of the difficulties of the research area is that 
tobacco smoke is composed of a large number of 
more or less potentially toxic chemical compounds, 
including `tars' and nicotine, but also several heavy 
metals like cadmium, hydroxyquinones, thiocyanate, 
nitrosamines and others [14].  
Reports on the effect of smoking on serum PTH 
have been conflicting. Few studies have shown a 
vitamin D dependent rise in PTH [15]. On the 
contrary, other studies demonstrated suppressed PTH 
levels despite low vitamin D levels [16]. The 
underlying mechanisms for this difference in serum 
PTH have not been fully investigated. However, 
confounding effects of weight, alcohol consumption, 
estrogen use, physical activity, sun exposure, and 
variability in calcium and vitamin D intake may 
account for the inconsistent PTH levels in published 
studies [17].  
2.  Materials and Methods 
To assess the effect of smoking on vitamin D, 
serum parathyroid hormone (PTH) and calcium we 
studied 86 postmenopausal women, who were 
smokers previously or who were current smokers.  Hysi & Rexha 
Their mean age was 59 years (50-70 years). Our 
results are compare with those of 34 women of the 
same age who had never smoked. 
Women with disease known to affect bone or 
calcium metabolism and those which are on Vitamin 
D supplement, were excluded  from the study.  
Patients taking Ca supplement were asked to stop 
these one week before being studied. Smoking status 
and fracture history was obtained by a standart 
questionnaire. 
Serum 25-hydroxyvitamin D (25(OH)D normal 
range 30-60 ng/ml, PTH (10-65 pg/ml) and Ca (8-11 
mg/dl) were measured on the fasting sample. We use 
the electrochemiluminescence assay (ECL) on Cobas 
6000 from Roche Diagnostics.  
Differences between the nonsmoking, smoking 
and exsmoking were evalueted using one-way 
analysis of variance.  
Differences between any two groups were 
analysed using student’s unpaired t-test. Significance 
limits was P<0.05. For the statistical analysis we used 
SPSS.20 programm. 
3.  Results and Discussion 
Mean level of PTH was lower in the 
postmenopausal women that are current smokers 
(30.78 pg/ml ± 9.024) compare with the nonsmokers 
and the exsmokers. Lower levels of 25OHD also were 
detected in smokers (20.08 ng/ml ± 4.232). (Table 1.). 
Analysis of the variables using the one way 
analysis of variance (ANOVA) showed that there 
were significant differences in the levels of serum 
PTH between nonsmoker, exsmoker and current 
smokers with Fs= 22.6 and P<0.001.  
Also significant differences we found and in the 
levels of 25OHD with Fs= 50.600 and P<0.001. But 
no defferences was found in serum calcium Fs= 
1.131and P=0.327 (P>0.05).  
 
Table 1. Mean and significance of differences of the parameters for the three groups  
  Nonsmokers Exsmokers  Smokers  P 
PTH (pg/ml)  44.3± 7.8  32.99 ± 9.67  30.78 ± 9.024  0.001 
25OHD (ng/ml)  37.9 ± 7.44  29.1 ± 8.55  20.08 ± 4.232  0.001 
Ca (mg/dl)  8.88 ± 0.47  8.74 ± 0.44  8.76 ± 0.329  0.327
ns 
 
   
(a) (b)  (c) 
Figure 1. a) Ca levels b) PTH levels c) Vitamin D levels. Differences between the three groups: 1. Non 
smokers 2. Ex smokers and 3. Current smokers 
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Table 2. Paired Samples Test 
  Paired Differences  t df  Sig.  (2-
tailed)  Mean SD SE 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Pair 1  PTH Non smokers – PTH 
Smokers 
13.491  6.729 1.154 11.143 15.839 11.690 33  .000 
Pair 2  VITD Non smokers – VITD 
Smokers 
17.038  8.722 1.495 13.994 20.081 11.389 33  .000 
Pair 3  Ca Non smokers – Ca Smokers  .119  .514  .088  -.059  .299  1.358  33  .184 
 
Differences between the two groups current 
smokers and non smokers were analysed using 
Student’s unpaired t-test.  
Postmenopausal women who were current 
smokers had significantly reduced levels of serum 
25OHD (P<0.01) and PTH (P<0.001) compared with 
nonsmokers. There was no difference in serum 
calcium between current smokers and nonsmokers 
(P=0.184). The unchanged plasma calcium among 
smokers in spite of lower levels of PTH and 25OHD 
could be a result of a decreased calcium uptake in 
bone. 
We can explain the lower levels of 25OHD 
among smokers with the fact that smoking may alter 
hepatic metabolism of vitamin D by influencing 25 
hydroxylase (CYP2R1) in the liver and lowering 
serum 25-OH-D, similar to the effect of smoking on 
enhanced hepatic degradation of estrogen The 
pathophysiologic mechanism for low 1,25-OH2-D 
levels in smokers has not been fully explored. 
However, it has been hypothesized that low calcitriol 
levels may be due to low availability of 25-OH-D, a 
metabolic precursor to 1,25-OH2-D, or potentially due 
to suppression of PTH release [18]. 
The reduced serum PTH among smokers might 
therefore be explained by a decrease secretion or an 
increased degradation of the hormone. Several 
hypotheses have been put forward concerning the 
mechanisms by which smoking affects bone, the main 
focus being on the antiestrogenic effect. Smokers are 
lean [19], have an early menopause [20], and have 
reduced levels of circulating oestrogens due to an 
increased hepatic turnover [21]. All these factors 
contribute to a reduced exposure to estrogen, resulting 
in an increased early bone loss. Other lifestyle factors 
are regarded as more prevalent among smokers 
compared to nonsmokers such as less physical 
activity, increased alcohol intake, or associated 
nutritional deficiencies, all of which might play a role.  
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